DR REDDYS LABORATORIES
Back to Income Statement
|
DR REDDYS LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹28,011 Cr | ₹24,670 Cr | ₹21,545 Cr | ₹19,048 Cr | ₹17,517 Cr |
What is the latest Revenue of DR REDDYS LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹28,011 Cr |
| Mar2024 | ₹24,670 Cr |
| Mar2023 | ₹21,545 Cr |
| Mar2022 | ₹19,048 Cr |
| Mar2021 | ₹17,517 Cr |
How is Revenue of DR REDDYS LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹28,011 Cr | 13.54 | |
| Mar2024 | ₹24,670 Cr | 14.50 | |
| Mar2023 | ₹21,545 Cr | 13.11 | |
| Mar2022 | ₹19,048 Cr | 8.74 | |
| Mar2021 | ₹17,517 Cr | - | |
Compare Revenue of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹105,914.9 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 2% | 2.4% | 11.2% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| MANKIND PHARMA | ₹90,491.0 Cr | 0.8% | -3% | -26.9% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -0.8% |
1.7% |
-5.6% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses